Form 4: Natera Executive Sells Shares for Tax Obligations

Natera's President of Clinical Diagnostics, Solomon Moshkevich, sold approximately $423,000 worth of common stock to satisfy tax obligations from RSU vesting.

Summary

• Solomon Moshkevich, President, Clinical Diagnostics of Natera, Inc. (NTRA), reported two sales of common stock.
• On October 27, 2025, 1,008 shares were sold at a price of $192.324 per share.
• On October 28, 2025, an additional 1,198 shares were sold at a price of $191.4619 per share.
• These sales were executed to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).
• The transactions were made pursuant to a written instruction intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
• Following these reported transactions, Moshkevich beneficially owns 115,061 shares of Natera common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary sale of shares by an executive to cover tax obligations associated with RSU vesting. This is a neutral event and does not indicate a change in the company's fundamental performance or the executive's confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape. It reflects a routine compensation-related event for an executive within the biotechnology or diagnostics sector.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in direct insider ownership, but it is for a non-discretionary tax purpose, which is a common occurrence and generally not viewed negatively. The underlying RSU vesting indicates continued executive compensation alignment.
• Employees: No direct impact on employees is indicated by this filing.
• Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

The reported transactions are routine sales by an executive to cover tax obligations arising from the vesting of Restricted Stock Units (RSUs). Such sales are common and typically do not reflect a change in the executive's outlook on the company's prospects or warrant a change in investment recommendation. The underlying RSU vesting is a standard component of executive compensation, and the subsequent tax-related sale is a mechanical event rather than a discretionary divestment.

Keywords

Natera, NTRA, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Executive Compensation, Solomon Moshkevich